2024年7月7日
479633-63-1,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-r.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Tofacitinib Impurity R CAS号 479633-63-1
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-related-compound-15.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Tofacitinib Impurity 13 CAS号 N/A 2024年7月7日
2056104-91-5,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-21.jpg
624
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Tofacitinib Impurity 15 CAS号 2056104-91-5 2024年7月7日
2459302-82-8,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-25.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Tofacitinib Impurity 19 CAS号 2459302-82-8 2024年7月7日
236750-65-5,Erlotinib
https://www.watson-int.cn/wp-content/uploads/2024/07/erlotinib-impurity-18.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Erlotinib Impurity 17 CAS号 236750-65-5 2024年7月7日
126150-57-0,Docetaxel
https://www.watson-int.cn/wp-content/uploads/2024/07/docetaxel-impurity-13.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Docetaxel Impurity 13 CAS号 126150-57-0 2024年7月7日
146924-91-6,Docetaxel
https://www.watson-int.cn/wp-content/uploads/2024/07/docetaxel-impurity-15.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Docetaxel Impurity 15 CAS号 146924-91-6 2024年7月7日
66147-29-3,Methotrexate
https://www.watson-int.cn/wp-content/uploads/2024/07/methotrexate-ep-impurity-i.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Methotrexate EP Impurity I CAS号 66147-29-3 2024年7月7日
4271-30-1,Methotrexate
https://www.watson-int.cn/wp-content/uploads/2024/07/methotrexate-ep-impurity-k.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Methotrexate EP Impurity K CAS号 4271-30-1 2024年7月7日
1032086-61-5,Olopatadine
https://www.watson-int.cn/wp-content/uploads/2024/07/olopatadine-impurity-1.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-07 00:13:30 2024-07-07 00:13:30 Olopatadine Impurity 1 CAS号 1032086-61-5
Scroll to top
Scroll to top
Scroll to top
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-r.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Tofacitinib Impurity R CAS号 479633-63-1
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-related-compound-15.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Tofacitinib Impurity 13 CAS号 N/A
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-21.jpg
624
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Tofacitinib Impurity 15 CAS号 2056104-91-5
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-25.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Tofacitinib Impurity 19 CAS号 2459302-82-8
https://www.watson-int.cn/wp-content/uploads/2024/07/erlotinib-impurity-18.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Erlotinib Impurity 17 CAS号 236750-65-5
https://www.watson-int.cn/wp-content/uploads/2024/07/docetaxel-impurity-13.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Docetaxel Impurity 13 CAS号 126150-57-0
https://www.watson-int.cn/wp-content/uploads/2024/07/docetaxel-impurity-15.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Docetaxel Impurity 15 CAS号 146924-91-6
https://www.watson-int.cn/wp-content/uploads/2024/07/methotrexate-ep-impurity-i.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Methotrexate EP Impurity I CAS号 66147-29-3
https://www.watson-int.cn/wp-content/uploads/2024/07/methotrexate-ep-impurity-k.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Methotrexate EP Impurity K CAS号 4271-30-1
https://www.watson-int.cn/wp-content/uploads/2024/07/olopatadine-impurity-1.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int2024-07-07 00:13:302024-07-07 00:13:30Olopatadine Impurity 1 CAS号 1032086-61-5